BC Week In Review | Mar 2, 2009
Company News

Celerus sales and marketing update

Celerus launched 12 antibodies to be used on its Celerus Wave System for immunohistochemistry analysis. The antibodies target CD7, CD8 , neutral endopeptidase (MME) (NEP) (CD10) , CD30 , CD34, CD79a, c-kit proto-oncogene protein (KIT, C-Kit, SCFR, CD117...
BC Innovations | Feb 12, 2009
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer Caudal type homeobox 1 (CDX1); keratin 20 (KRT20; CK20) In vitro studies suggest that enhancing CDX1 activity could help...
Items per page:
1 - 2 of 2